Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Carnero López

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 27, 2007
Renal primary angiosarcomaB Carnero López, I Fernández Pérez, J A Carrasco Alvarez, et al.
Clinical and Experimental Rheumatology|December 20, 2013
Gelsolin levels are decreased in ankylosing spondylitis patients undergoing anti-TNF-alpha therapyF Genre, R López-Mejías, J A Miranda-Filloy, et al.
Clinical and Experimental Rheumatology|December 4, 2013
Correlation between two biomarkers of atherosclerosis, osteopontin and angiopoietin-2, in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapyF Genre, R López-Mejías, J A Miranda-Filloy, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 27, 2007
Renal primary angiosarcomaB Carnero López, I Fernández Pérez, J A Carrasco Alvarez, et al.
Clinical and Experimental Rheumatology|December 20, 2013
Gelsolin levels are decreased in ankylosing spondylitis patients undergoing anti-TNF-alpha therapyF Genre, R López-Mejías, J A Miranda-Filloy, et al.
Clinical and Experimental Rheumatology|December 4, 2013
Correlation between two biomarkers of atherosclerosis, osteopontin and angiopoietin-2, in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapyF Genre, R López-Mejías, J A Miranda-Filloy, et al.
Pageof 1